R-CEOP Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of cyclophosphamide, etoposide, vincristine, prednisone and rituximab that may be used in the treatment of diffuse large B-cell lymphoma (DLBCL) and post-transplant lymphoproliferative disorders.

**Synonyms:** - CEOP Plus Rituximab Regimen - CEOP/Rituximab Regimen - Cyclophosphamide-Etoposide-Prednisone-Rituximab-Vincristine - Cyclophosphamide-Etoposide-Prednisone-Rituximab-Vincristine Regimen - Cyclophosphamide/Etoposide/Oncovin/Prednisone Plus Rituxan Regimen - Cyclophosphamide/Etoposide/Prednisone/Rituximab/Vincristine - Cyclophosphamide/Etoposide/Prednisone/Rituximab/Vincristine Regimen - R-CEOP (Etoposide) - R-CEOP (Etoposide) (rituximab-abbs) - R-CEOP (Etoposide) (rituximab-arrx) - R-CEOP (Etoposide) (rituximab-blit) - R-CEOP (Etoposide) (rituximab-pvvr) - R-CEOP (Etoposide) (rituximab-rite) - R-CEOP (Etoposide) (rituximab-rixa) - R-CEOP (Etoposide) (rituximab-rixi)